The neuropeptide hormone arginine vasopressin (AVP) is synthesised in magnocellular neurones of the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus. Increases in plasma osmolality are detected by osmosensitive neurones in circumventricular organs that provide direct excitatory inputs leading to increased *Avp* synthesis by magnocellular neurones of the SON and PVN, as well as AVP secretion from the posterior pituitary [1](#jne12371-bib-0001){ref-type="ref"}. An increase in plasma osmolality of only 1% is sufficient to drive increased AVP synthesis and secretion [2](#jne12371-bib-0002){ref-type="ref"}. Vasopressin synthesis and secretion is also sensitive to non‐osmotic cues, including changes in blood volume and pressure [3](#jne12371-bib-0003){ref-type="ref"}, [4](#jne12371-bib-0004){ref-type="ref"}, [5](#jne12371-bib-0005){ref-type="ref"}, [6](#jne12371-bib-0006){ref-type="ref"}, [7](#jne12371-bib-0007){ref-type="ref"}. A decrease in blood volume (hypovolaemia) is detected by the cardiac right atrium, again resulting in increased AVP synthesis and secretion [8](#jne12371-bib-0008){ref-type="ref"}. In this regard, changes in blood volumes greater than 8% are necessary to facilitate this response [3](#jne12371-bib-0003){ref-type="ref"}, [5](#jne12371-bib-0005){ref-type="ref"}, [9](#jne12371-bib-0009){ref-type="ref"}, [10](#jne12371-bib-0010){ref-type="ref"}. A population of smaller AVP expressing parvocellular neurones is also found in the PVN, which is important in co‐ordinating responses to stress [11](#jne12371-bib-0011){ref-type="ref"}.

The two osmotic stimuli of dehydration and salt loading both robustly increase *Avp* mRNA levels by approximately two‐fold in the SON and PVN, with parallel increases in the secretion of AVP [5](#jne12371-bib-0005){ref-type="ref"}, [9](#jne12371-bib-0009){ref-type="ref"}, [12](#jne12371-bib-0012){ref-type="ref"}. Notably, dehydration also decreases blood volume in rats, with \> 20% reductions in volume by 3 days [5](#jne12371-bib-0005){ref-type="ref"}, [9](#jne12371-bib-0009){ref-type="ref"}, [13](#jne12371-bib-0013){ref-type="ref"}; thus, dehydration can be considered as both an osmotic and hypovolaemic stimulus. The prolonged exposure to either of these stimuli causes functional remodelling of both brain nuclei as a consequence of persistent neuronal activation, a process referred to as function‐related plasticity [14](#jne12371-bib-0014){ref-type="ref"}. The visible outcomes of prolonged hyperosmotic stimulation of the PVN and SON are increased volumes of magnocellular neurones and a retraction of glial processes, which is reversed upon cessation of the stimulus [14](#jne12371-bib-0014){ref-type="ref"}, [15](#jne12371-bib-0015){ref-type="ref"}. The hypertrophy of magnocellular neurones is recognised to be a result of the large increase in transcription and protein synthesis under hyperosmotic stimulation. In this regard, catalogues of differentially expressed genes have been reported in the SON and PVN in response to both dehydration and salt loading that are consistent with increased levels of transcription [16](#jne12371-bib-0016){ref-type="ref"}, [17](#jne12371-bib-0017){ref-type="ref"}, [18](#jne12371-bib-0018){ref-type="ref"}. These lists include the up‐regulated expression of a wide array of transcription factors that, through their interaction at the promoters of target genes, are important for this wave of increased transcriptional activity.

A previous study has suggested that brain plasticity is dependent upon epigenetic mechanisms resulting in stable modulation of gene expression [19](#jne12371-bib-0019){ref-type="ref"}. Indeed, a study by Guo *et al*. [20](#jne12371-bib-0020){ref-type="ref"} reported that increased neuronal activity could promote vast methylation changes throughout the genome. The epigenetic modification receiving most attention is methylation of CpG (cytosine‐phosphate‐guanine) sites. The notion that the methylation of genomic DNA was stable in adult life is now discredited. The adult brain expresses high levels of DNA methyltransferases (*Dnmt*) that are involved in the active maintenance and *de novo* methylation of CpG residues in genomic DNA [21](#jne12371-bib-0021){ref-type="ref"}, [22](#jne12371-bib-0022){ref-type="ref"}. In addition, the ten‐eleven‐translocation (*Tet*) genes are also abundant in the brain and act to facilitate active demethylation at CpG residues [23](#jne12371-bib-0023){ref-type="ref"}. Increased methylation is commonly associated with transcriptional inhibition, although, in some cases, transcriptional activation has also been reported [24](#jne12371-bib-0024){ref-type="ref"}. Thus, we proposed that changes in methylation may contribute to the plastic response in the hypothalamus in response to dehydration and salt loading.

We focused our attention on the *Avp* promoter. The *Avp* gene has been the subject of a number of methylation studies in both the rat and mouse hypothalamus and other brain regions [25](#jne12371-bib-0025){ref-type="ref"}, [26](#jne12371-bib-0026){ref-type="ref"}, [27](#jne12371-bib-0027){ref-type="ref"}, [28](#jne12371-bib-0028){ref-type="ref"}. The methylation status of the mouse *Avp* gene has been comprehensively described in the PVN, where early‐life stress results in hypomethylation at CpGs sites in a putative enhancer within the intergenic region between the *Avp* gene and the gene encoding the closest related hormone oxytocin, which was shown to be consistent with increased *Avp* expression in adult animals [27](#jne12371-bib-0027){ref-type="ref"}. A subsequent study showed that the methylation patterns of these CpG sites were also altered by age, suggesting that alterations in methylation signatures within the *Avp* gene could be influenced by events later in life [28](#jne12371-bib-0028){ref-type="ref"}.

Four CpG islands have been identified for the *Avp* gene, and the so named CpG island 1 spans the proximal promoter region of the *Avp* gene [27](#jne12371-bib-0027){ref-type="ref"}, [29](#jne12371-bib-0029){ref-type="ref"}. The proximal portion of the *Avp* promoter includes a number of potential transcription factor binding sites, including activator proteins 1 and 2, cAMP responsive element (CRE) sites, and E‐box and G‐box elements [30](#jne12371-bib-0030){ref-type="ref"}, [31](#jne12371-bib-0031){ref-type="ref"}. We recently reported that CREB3L1 is a transcription factor of the *Avp* gene and, using chromatin immunoprecipitation, showed that it binds within the first few hundred bases upstream of the transcriptional start site [30](#jne12371-bib-0030){ref-type="ref"}. The immediate early genes *c‐Fos* and *c‐Jun*, as well as CREB, have also been implicated in induction of *Avp* transcription via interactions with this segment of DNA [31](#jne12371-bib-0031){ref-type="ref"}, [32](#jne12371-bib-0032){ref-type="ref"}, [33](#jne12371-bib-0033){ref-type="ref"}. Methylation was shown to inhibit transcription factor interactions with DNA either directly or through the recruitment of methyl binding proteins [34](#jne12371-bib-0034){ref-type="ref"}. Thus, we reasoned that the proximal promoter may be subjected to methylation changes in the hypothalamus in response to hyperosmotic stress.

We examined the methylation status of the proximal *Avp* promoter in the SON in response to the hyperosmotic stressors of dehydration and salt loading. The SON was the region of choice because it contains only magnocellular neurones, whereas the PVN is more heterogenous with respect to its neuronal phenotypes and physiological functions. We found that dehydration induces hypermethylation of the proximal *Avp* promoter, whereas the methylation status was not altered by salt loading.

Materials and methods {#jne12371-sec-0002}
=====================

Animals {#jne12371-sec-0003}
-------

Male Sprague--Dawley rats weighing 275--300 g were used in the present study. Rats were maintained under a 14 : 10 h light/dark cycle (lights on 05.00 h) with food and water available *ad lib*. for at least 1 week prior to experimentation. Animal experiments were performed between 09.00 h and 11.00 h. To induce hyperosmotic stress, either water was removed for 3 days of dehydration or replaced by 2% (w/v) NaCl in drinking water for 7 days as a protocol for salt loading. All rats were humanely killed by striking of the cranium (stunning) and then immediately decapitated with a small animal guillotine (Harvard Apparatus, Holliston, MA, USA). Brains were rapidly removed from the cranium and frozen on dry ice (within 3 min after stunning) before being stored at −80 °C. All experiments were performed under a Home Office UK licence held under, and in strict accordance with, the provision of the UK Animals (Scientific Procedures) Act (1986); they had also been approved by the University of Bristol Animal Welfare and Ethical Review board.

Duel extraction of DNA and RNA from the same sample {#jne12371-sec-0004}
---------------------------------------------------

Frozen brains were sliced into 60‐μm coronal sections in a cryostat. Sections were mounted on glass slides and stained with 0.1% (w/v) toludine blue, then visualised on a light microscope until magnocellular neurones of the SON were visible. SON samples (24 punches) were collected from twelve coronal slices using a 0.35‐mm sample corer (Fine Science Tools, Foster City, CA, USA) using the optic chiasm as a reference. Punches were dispensed into 0.5‐ml tubes kept on dry ice within the cryostat. Cortex samples (four punches) were collected from two consecutive sections after SON collection using a 0.8‐mm sample corer to obtain similar quantities of tissue (Fine Science Tools). Total RNA and genomic DNA were extracted from each sample using ZR‐Duet DNA/RNA MiniPrep kit (Zymo Research, Irvine, CA, USA). The punch samples (SON and cortex) were removed from dry ice and rapidly resuspended, by vortexing, in 400 μl of DNA/RNA lysis buffer. Subsequent steps were performed in accordance with the manufacturer\'s instructions.

For *in vitro* studies, the culture medium was removed and the cells were lysed in 350 μl of Qiazol Reagent (Qiagen, Valencia, CA, USA). The lysate was mixed with 350 μl of absolute ethanol and added directly into the Direct‐zol™ RNA MiniPrep columns (Zymo Research; R2052) and extraction continued in accordance with the manufacturer\'s instructions. The concentrations of DNA and RNA were determined using a NanoDrop (Thermo Scientific, Waltham, MA, USA).

Bisulphite conversion of DNA and TA cloning {#jne12371-sec-0005}
-------------------------------------------

Genomic DNA from SON and cortex punches (50 ng) and rat hypothalamic 4B cells (200 ng) was bisulphite converted using EZ DNA Methylation‐Gold kit (Zymo Research). Primers for amplification of bisulphite converted DNA were designed using [methprimer]{.smallcaps} [35](#jne12371-bib-0035){ref-type="ref"}. The converted DNA was amplified with rat *Avp* promoter primers (5′‐TTGTTGAGAGTTGTTGAAATGTTTAAT‐3′ and 5′‐TTTATATCTACAAATATTAACTAAAAAAC‐3′) using the cycling conditions: 94 °C for 2 min followed by 45 cycles of 94 °C for 30 s, 50 °C for 30 s and 72 °C for 2 min. Polymerase chain reactions (PCRs) were performed using Platinum Taq DNA Polymerase (Life Technologies, Grand Island, NY, USA). The PCR products were purified using Qiagen\'s PCR purification kit, ligated into pGEM‐T Easy vector (Promega, Madison, WI, USA), and transformed into DH5α competent *Escherichia coli* cells. Positive clones were selected by blue/white colony selection on liquid broth agar plates supplemented with X‐Gal and isopropyl β‐[d]{.smallcaps}‐1‐thiogalactopyranoside. Plasmid DNA was extracted from overnight bacterial cultures using a QIAprep Spin Miniprep kit (Qiagen) and the presence of inserts was verified by restriction digestion with *Eco*RI. Twenty independent clones were sequenced per SON sample and 10 independent clones per sample for cortex and hypothalamic 4B cells.

Cell treatments {#jne12371-sec-0006}
---------------

Rat hypothalamic 4B cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) (Sigma, St Louis, MO, USA; D6546) supplemented with 10% (v/v) heat‐inactivated foetal bovine serum (Gibco, Gaithersburg, MD, USA), 2 m[m l]{.smallcaps}‐glutamine and 100 units/ml of penicillin‐streptomycin. Cells were incubated at 37 °C in a humidified incubator with 5% (v/v) CO~2~. For chemical treatments, cells were seeded onto tissue culture plates to 60--70% confluence. After 24 h, cells were treated with 1, 2.5, 5 or 10 μ[m]{.smallcaps} of DNA methyltransferase inhibitor [36](#jne12371-bib-0036){ref-type="ref"}, 5‐Aza‐2′‐deoxycytidine (5‐Aza; Sigma, A3656) for 48 h. For activation of the cAMP pathway, cells were treated with 10 μM forskolin (Sigma: F6886) or dimethyl sulphoxide (DMSO) (vehicle) for 4 h. Stock solutions of 5‐Aza (10 m[m]{.smallcaps}) and forskolin (10 m[m]{.smallcaps}) were prepared in DMSO.

cDNA synthesis and quantitative PCR analysis {#jne12371-sec-0007}
--------------------------------------------

For cDNA synthesis, total RNA (50 ng for punch samples, 500 ng for hypothalamic 4B cells) was reverse transcribed using the Quantitect reverse transcription kit (Qiagen). Primers for *Avp* (5′‐TGCCTGCTACTTCCAGAACTGC‐3′ and 5′‐AGGGGAGACACTGTCTCAGCTC‐3′), heteronuclear *Avp* (*hnAvp*) (5′‐GAGGCAAGAGGGCCACATC‐3′ and 5′‐CTCTCCTAGCCCATGACCCTT‐3′), *c‐Fos* (5′‐AGCATGGGCTCCCCTGTCA‐3′ and 5′‐GAGACCAGAGTGGGCTGCA‐3′), *Creb3l1* (5′‐GCCAACAGGACCCTGCTCCA‐3′ and 5′‐AGTGCCAGTCTGTGTGGCCG‐3′), *Dnmt1* (5′‐AACCACTCAGCATTCCCGTA‐3′ and 5′‐TGCTGGTACTTCAGGTCAGG‐3′), *Dnmt3a* (5′‐AAGACCCCTGGAACTGCTAC‐3′ and 5′‐TGGCGAAGAACATCTGGAGT‐3′), *Tet1* (5′‐TGACCCACTCTTACCAGACC‐3′ and 5′‐GATGGGCCATTGCTTGATGT‐3′), *Tet2* (5′‐TCGGAGGAGAAGAGTCAGGA‐3′ and 5′TAGGGCTTGCATTTTCCATC‐3′), *Tet3* (5′‐ATGGCATGAAACCACCCAAC‐3′ and 5′‐ACTTGATCTTCCCCTCCAGC‐3′) and *Rpl19* (5′‐GCGTCTGCAGCCATGAGTA‐3′ and 5′‐TGGCATTGGCGATTTCGTTG‐3′) were synthesised by Eurofins MWG Operon (Ebersberg, Germany). The optimisation and validation of primers was performed using standard ABI protocols. The cDNA from reverse transcription reaction was diluted 1 : 4 with ddH~2~O and used as a template for subsequent PCRs, which were carried out in duplicate using SYBR green (Roche, Basel, Switzerland) on an ABI StepOnePlus Real‐Time PCR system (Applied Biosystems, Foster City, CA, USA). For relative quantification of gene expression, the 2^−ΔΔ*CT*^ method was employed [37](#jne12371-bib-0037){ref-type="ref"}. The internal control gene used for these analyses was the housekeeping gene Rpl19.

Construction of *Avp* promoter mutants by overlap extension PCR {#jne12371-sec-0008}
---------------------------------------------------------------

A series of mutant rat *Avp* promoter luciferase constructs were generated by overlap extension PCR. Primers 350‐F (5′‐CGGGGTACCAATGAGACCTGGGGACCCCT‐3′) and 350‐R (5′‐CCCGCTCGAGCCTGAGCGGGCTGGGCTGT‐3′) were designed to amplify 350 bp of the rat *Avp* promoter, and contained *Kpn*I and *Xho*I restriction sites, respectively. These primers were used in combination with deletion specific forward and reverse primers to amplify *Avp* promoter fragments using Phusion High‐Fidelity DNA Polymerase (New England Biolabs, Beverly, MA, USA). The PCR products from the initial PCRs were combined and used as template for a subsequent PCR using primers 350‐F and 350‐R. Mutations (C‐A) were performed for six separate CpG sites and complete 350‐bp fragments were ligated into *Kpn*I and *Xho*I sites of pGL3‐Basic plasmid (Promega). The primers used for creation of site‐directed mutations were:

CpG1 (5′‐CCCTCAAGTAGGCTCACCTCCC‐3′ and 5′‐GGGAGGTGAGCCTACTTGAGGG‐3′), CpG2 (5′‐TCACTGTGGAGGTGGCTCCCG‐3′ and 5′‐CGGGAGCCACCTCCACAGTGA‐3′),CpG3 (5′‐CGGTGGCTCCAGTCACACGGTG‐3′ and 5′‐CACCGTGTGACTGGAGCCACCG‐3′),CpG4 (5′‐CCCGTCACAAGGTGGCCAGTG‐3′ and 5′‐CACTGGCCACCTTGTGACGGG‐3′),CpG6 (5′‐TTAGCAGCCAAGCTGTCGCCTCC‐3′ and 5′‐GGAGGCGACAGCTTGGCTGCTAA‐3′) and CpG7 (5′‐GCCACGCTGTAGCCTCCTAGCCA‐3′ and 5′‐TGGCTAGGAGGCTACAGCGTGGC‐3′).

*In vitro* methylation of plasmid DNA {#jne12371-sec-0009}
-------------------------------------

Methylation of *Avp* promoter constructs was performed using CpG methyltransferase (M0226L; NEB) in accordance with the manufacturer\'s instructions. Mock methylation reactions were performed for all plasmids with identical reaction chemistry but with the omission of CpG methyltransferase. The methylation reactions were incubated at 37 °C for 8 h followed by 65 °C for 20 min. Plasmid DNA was purified using a QIAprep Spin Miniprep kit. To confirm methylation, plasmids were cut with methylation sensitive restriction enzyme *Pml*I (CACGTG), which recognises CpG site 5 within the *Avp* promoter of the pGL3‐*Avp* promoter constructs.

Luciferase assay {#jne12371-sec-0010}
----------------

Human embryonic kidney cells HEK293T/17 (ATTC CRL‐11268) were cultured in DMEM (Sigma; D6546) supplemented with 10% (v/v) heat‐inactivated foetal bovine serum (Gibco, Gaithersburg, MD, USA), 2 m[m l]{.smallcaps}‐glutamine and 100 units/ml of penicillin‐streptomycin. Cells were incubated at 37 °C in a humidified incubator with 5% (v/v) CO~2~. For luciferase assays, 3 × 10^5^ cells/well were seeded in 12‐well tissue culture plates in the absence of antibiotics. The next day, plasmids (0.5 μg of pGL3‐*Avp* promoter and 0.5 μg of pcDNA3 or pcDNA3‐*Creb3l1* and 0.05 μg of pRL‐TK vector/well) were transfected with FuGENE HD transfection reagent (Promega). The culture media was replaced with fresh media at 8 h after transfection. Luciferase assays were performed using Promega\'s Dual‐Luciferase^®^ Reporter Assay kit. At 36 h after transfection, culture media was removed and cells were washed with phosphate‐buffered saline and lysed with 500 μl of the supplied lysis buffer. Luciferase activity was measured using a Lumat LB 9507 Luminometer (Berthold Technologies GmbH, Bad Wildbad, Germany).

Statistical analysis {#jne12371-sec-0011}
--------------------

One‐way [anova]{.smallcaps} with Tukey\'s post‐hoc test were used to determine the difference between more than two samples with only a single influencing factor. Two‐way [anova]{.smallcaps} with a Bonferonni post‐hoc test was used to determine interactions between two independent variables on the dependent variable. In some cases, statistical differences between two experimental groups were evaluated using an independent‐sample unpaired Student\'s t‐test. Correlations were performed using Pearson\'s correlation coefficient. P \< 0.05 was considered statistically significant.

Results {#jne12371-sec-0012}
=======

CpG sites in the proximal *Avp* promoter {#jne12371-sec-0013}
----------------------------------------

The *Avp* gene is comprised of three exons and two introns (Fig. [1](#jne12371-fig-0001){ref-type="fig"} [a]{.smallcaps}). Computational studies mapping the distribution of CpG residues throughout the *Avp* gene have described the location of a CpG island in the proximal Avp promoter region [27](#jne12371-bib-0027){ref-type="ref"}. We focused our attention on seven CpG residues in this CpG island (Fig. [1](#jne12371-fig-0001){ref-type="fig"} [b]{.smallcaps}). This region of the Avp promoter contains a number of transcription factor binding motifs.

![Schematic diagram of the *Avp* gene and the presence of CpG (cytosine‐phosphate‐guanine) sites in the proximal promoter region. ([a]{.smallcaps}) *Avp* gene contains three exons indicated by open boxes. The primers used to amplify the 302‐bp *Avp* promoter are indicated. ([b]{.smallcaps}) Transcription factor binding sites (highlighted) and CpG sites (red) investigated within the 350 bp of *Avp* promoter are shown. The location of forward and reverse primers for amplification of bisulphite converted DNA are underlined. Lower: location of CpG sites in the *Avp* promoter. TSS, transcription start site; CAAT box; CRE,cAMP response element; AP, activator protein.](JNE-28-0-g001){#jne12371-fig-0001}

Demethylation of the *Avp* promoter dramatically increases *Avp* transcription {#jne12371-sec-0014}
------------------------------------------------------------------------------

We first looked at *Avp* promoter methylation in an immortalised rat hypothalamic cell line 4B. Hypothalamic 4B cells are derived from embryonic day 19 rat hypothalamus and have a neuronal phenotype expressing corticotrophin‐releasing hormone, *Avp* and glucocorticoid receptors similar to parvocellular neurones of the hypothalamus [38](#jne12371-bib-0038){ref-type="ref"}. We found high methylation of the *Avp* promoter region in hypothalamic 4B cells (Fig. [2](#jne12371-fig-0002){ref-type="fig"} [a]{.smallcaps}). Treatment of hypothalamic 4B cells with the DNA methyltransferase inhibitor 5‐Aza dramatically increased *Avp* expression (Fig. [2](#jne12371-fig-0002){ref-type="fig"} [b]{.smallcaps}). We treated cells with 5‐Aza in the presence or absence of forskolin (Fig. [2](#jne12371-fig-0002){ref-type="fig"} [c]{.smallcaps}). Forskolin alone increased *Avp* synthesis and further enhanced responses to 5‐Aza treatment, suggesting that methylation regulates cAMP induced *Avp* synthesis.

![Demethylation of the *Avp* promoter dramatically increases *Avp* transcription in hypothalamic 4B cells. ([a]{.smallcaps}) Tile diagram showing the methylation status of CpG (cytosine‐phosphate‐guanine) sites for individual clones of the *Avp* promoter from the hypothalamic 4B cells. ([b]{.smallcaps}) Treatment of hypothalamic 4B cells with DNA methyltransferase inhibitor 5‐Aza‐dc (1--10 μ[m]{.smallcaps}) increases *Avp* synthesis. ([c]{.smallcaps}) Forskolin (10 μ[m]{.smallcaps}) induced *Avp* synthesis was further enhanced by 5‐Aza treatment. Error bars indicate the mean ± SEM (n = 4 per group). \*\*\*P \< 0.001 ([b]{.smallcaps}, one‐way [anova]{.smallcaps} with Tukey\'s post‐hoc test; [c]{.smallcaps}, two‐way [anova]{.smallcaps} with a Bonferonni post‐hoc test). DMSO, dimethyl sulphoxide.](JNE-28-0-g002){#jne12371-fig-0002}

Decreased expression of Tet2 in the SON of dehydrated and salt‐loaded rats {#jne12371-sec-0015}
--------------------------------------------------------------------------

We used a micro punch to isolate SON samples aiming to minimise contamination from surrounding brain regions (Fig. [3](#jne12371-fig-0003){ref-type="fig"}). Our data replicate previous findings showing that *hnAvp* expression is robustly induced in the SON by the two osmotic stimuli of dehydration and salt loading (Fig. [3](#jne12371-fig-0003){ref-type="fig"} [a]{.smallcaps}) [5](#jne12371-bib-0005){ref-type="ref"}. As expected, using immediate early gene *c‐Fos* (Fig. [3](#jne12371-fig-0003){ref-type="fig"} [a]{.smallcaps}), a marker of neuronal activity, we confirmed comparable increases in neuronal activity in both dehydrated and salt‐loaded rat SON. We have recently identified transcription factor CREB3L1 as a putative transcriptional regulator of the *Avp* gene and confirm here that *Creb3l1* is induced by dehydration and salt loading (Fig. [3](#jne12371-fig-0003){ref-type="fig"} [a]{.smallcaps}) [30](#jne12371-bib-0030){ref-type="ref"}. To determine whether changes in methylation may underlie the increased transcription of *Avp*, we looked at the mRNA expression of *Dnmt* and *Tet* genes in the SON (Fig. [3](#jne12371-fig-0003){ref-type="fig"} [a]{.smallcaps}). We found no changes in expression of *Dnmt1*,*Dnmt3a*,*Tet1* or *Tet3* in the SON of dehydrated or salt‐loaded rats compared to controls. By contrast, *Tet2* expression was significantly decreased in SON by both stimuli. We chose to examine gene expression in an unrelated brain region, the cortex (Fig. [3](#jne12371-fig-0003){ref-type="fig"} [b]{.smallcaps}). In this brain region, *Avp* expression was undetectable, and there were no differences in the expression of any of the genes examined compared to controls, with the exception of increased *c‐Fos* in salt‐loaded animals.

![mRNA expression of genes involved in hyperosmotic stress and methylation in the supraoptic nucleus (SON) and cortex of dehydrated and salt‐loaded rats. ([a]{.smallcaps}) Brain section stained with 1% (w/v) toludine blue/70% (v/v) ethanol shows the punched area of the SON. The high magnification image shows that the punch samples were confined within the area of magnocellular neurones of the SON. cDNA synthesis and subsequent quantitative polymerase chain reaction analysis was performed using RNA extracted from these punch samples. mRNA expression of hn*Avp*,*c‐Fos*,*Creb3l1*,*Dnmt1*,*Dnmt3a*,*Tet1*,*Tet2* and *Tet3* was examined in SON ([a]{.smallcaps}) and cortex ([b]{.smallcaps}). Error bars indicate the mean ± SEM (n = 4--5 per group). \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 (one‐way [anova]{.smallcaps} with Tukey\'s post‐hoc test). OC, optic chiasm; MCN, magnocellular neurone; DH, dehydration; SL, salt loading; hn*Avp*, heteronuclear RNA of *Avp*. Scale bar = 200 μm.](JNE-28-0-g003){#jne12371-fig-0003}

Change in methylation status of the *Avp* promoter in the dehydrated rat {#jne12371-sec-0016}
------------------------------------------------------------------------

We examined the methylation profile of the *Avp* promoter within the SON by sequence analysis of bisulphite converted DNA (Fig. [4](#jne12371-fig-0004){ref-type="fig"}). Using primers spanning the proximal *Avp* promoter (−325 to −24), we investigated the methylation status of this cluster of seven CpG sites. Analyses of the methylation pattern of CpGs in single clones from individual control, dehydrated and salt‐loaded animals are depicted in Fig. [4](#jne12371-fig-0004){ref-type="fig"}([a)]{.smallcaps}. These data showed that all CpGs in this region have some degree of methylation under all experimental conditions. Analysis of the overall methylation of the *Avp* promoter for the SON revealed increased methylation in dehydrated compared to control and salt‐loaded animals (Fig. [4](#jne12371-fig-0004){ref-type="fig"} [b]{.smallcaps}). In comparison, methylation was not significantly affected by dehydration or salt loading in the cortex (Fig. [4](#jne12371-fig-0004){ref-type="fig"} [b]{.smallcaps}).

![Methylation status of the *Avp* promoter in response to dehydration and salt loading in the supraoptic nucleus (SON). Genomic DNA was extracted from the SON and cortex of control, 3 days dehydrated and 7 days salt‐loaded rats (n = 4--5). The DNA was bisulphite converted, *Avp* promoter region amplified and cloned into TA vector for sequencing (n = 20 for each sample). ([a]{.smallcaps}) Tile diagrams showing the methylation status of seven CpG (cytosine‐phosphate‐guanine) sites for individual clones of the *Avp* promoter extracted from the SON. ([b]{.smallcaps}) Percentage of global methylation on the *Avp* promoter in the SON and cortex of dehydrated and salt‐loaded rats is shown. ([c, d]{.smallcaps}) Change in methylation status of CpGs in ([c]{.smallcaps}) SON and ([d]{.smallcaps}) cortex *Avp* promoters in response to dehydration and salt loading. ([e]{.smallcaps}) Correlation analysis of methylation level with the expression of hn*Avp* in control SON samples. ([f]{.smallcaps}) Methylation level of CpG 1--7 on the *Avp* promoter of dehydrated and salt‐loaded rats compared to control. Black, hypermethylation; white, hypomethylation; grey, no change in methylation level compared to control. Error bars indicate the mean ± SEM (n = 4--5 per group). \*P \< 0.05, \*\*P \< 0.01 (one‐way [anova]{.smallcaps} with Tukey\'s post‐hoc test); ^\#^P \< 0.05 (unpaired t‐test); DH, dehydration; SL, salt loading.](JNE-28-0-g004){#jne12371-fig-0004}

We next compared the methyation profiles of the three experimental groups. Of the seven CpGs analysed, five showed increased methylation (CpGs 2, 3, 4, 6 and 7), one showed decreased methylation (CpG1) and one showed no change of methylation (CpG5) in the SON of dehydrated compared to control animals (Fig. [4](#jne12371-fig-0004){ref-type="fig"} [c]{.smallcaps}). By contrast, methylation of the *Avp* promoter was not altered in the SON by salt loading. To determine whether these changes were specific to the SON, we used the same method to look at *Avp* promoter methylation in the cortex of these animals (Fig. [4](#jne12371-fig-0004){ref-type="fig"} [d]{.smallcaps}). Of note, the pattern of methylation displayed across these CpGs was remarkably similar in the SON and cortex of controls, suggesting that this pattern was not unique to the SON. By contrast to the SON, dehydration only significantly influenced methylation of CpG7 in the *Avp* promoter in the cortex. However, salt loading also had no affect on methylation in the cortex.

We performed correlation analyses, comparing the methylation status of individual CpG residues with the expression of hn*Avp* in the same control sample (Fig. [4](#jne12371-fig-0004){ref-type="fig"} [e]{.smallcaps}). Of the six CpGs that showed significant changes in methylation status in dehydration, only two CpGs (CpG3 and 4) had methylation patterns that were strongly correlated with the hn*Avp* expression in control animals. The strong negative correlation between *Avp* promoter methylation level and *Avp* hnRNA abundance is consistent with a role for methylation in transcriptional inhibition. In dehydrated and salt‐loaded animals, we observed no correlation between methylation of individual CpGs and hn*Avp* expression. A summary of the overall methylation changes is depicted in Fig. [4](#jne12371-fig-0004){ref-type="fig"}([f]{.smallcaps}).

*In vitro* methylation of CpG sites in the *Avp* promoter alters promoter activity {#jne12371-sec-0017}
----------------------------------------------------------------------------------

We then used *Avp* promoter‐luciferase reporter assays to further explore the effect of methylation on *Avp* transcription (Fig. [5](#jne12371-fig-0005){ref-type="fig"}). Using the technique of overlap extension PCR, we replaced the nucleotide cytosine with adenine (C‐A) for CpG sites [1](#jne12371-bib-0001){ref-type="ref"}, [2](#jne12371-bib-0002){ref-type="ref"}, [3](#jne12371-bib-0003){ref-type="ref"}, [4](#jne12371-bib-0004){ref-type="ref"}, [6](#jne12371-bib-0006){ref-type="ref"}, [7](#jne12371-bib-0007){ref-type="ref"} aiming to prevent *in vitro* methylation of these residues by CpG methyltransferase (Fig. [5](#jne12371-fig-0005){ref-type="fig"} [a]{.smallcaps}). We did not examine CpG5 because the methylation status of this site was not altered in the SON by dehydration or salt loading. The methylation status of our promoter constructs was confirmed by a failure to digest the plasmid DNA with *Pml*I (Fig. [5](#jne12371-fig-0005){ref-type="fig"} [b]{.smallcaps}). We performed luciferase assays to test whether manipulation of these single nucleotides altered *Avp* promoter activity (Fig. [5](#jne12371-fig-0005){ref-type="fig"} [c]{.smallcaps}). The C‐A substitution at CpG3, which resides in the CRE site, increased *Avp* promoter activity, whereas, at the more proximal CpG7 site, *Avp* promoter activity decreased. Next, we transfected HEK293T cells with transcription factor *Creb3l1* overexpression construct to test whether induced *Avp* transcription was altered by any of these manipulations. For CpG4, 6 and 7, C‐A substitution reduced *Creb3l1* mediated transcriptional activation of the *Avp* promoter, suggesting that those nucleotides are important for transcriptional activation by *Creb3l1*. We then investigated the effect of *in vitro* methylation by CpG metyltransferase on *Avp* promoter activity of these constructs (Fig. [5](#jne12371-fig-0005){ref-type="fig"} [d]{.smallcaps}). After methylation, CpG1, 4 and 7 constructs displayed lower promoter activity, suggesting that the methylation status of these sites was intrinsically important for *Avp* promoter activity. In response to *Creb3l1*, methylation of CpG1, 4, 6 and 7 constructs decreased, whereas CpG2 and 3 increased, promoter activity.

![Methylation of CpG (cytosine‐phosphate‐guanine) sites on the *Avp* promoter *in vitro*. The substitution (C‐A) at CpG sites in the *Avp* promoter by overlap extension polymerase chain reaction was used to prevent methylation at specific CpG sites. The mutation sites are shown in ([a]{.smallcaps}). The mutated plasmids were subsequently methylated by methyltransferase enzyme. ([b]{.smallcaps}) Successful methylation was determined using methylation sensitive restriction enzyme *Pml*I. (c, [d]{.smallcaps}) Luciferase assays were performed by co‐transfection of plasmid expressing *Creb3l1* and 350 bp *Avp* promoter contructs with ([c]{.smallcaps}) unmethylated and ([d]{.smallcaps}) methylated plasmid. Error bars indicate the mean ± SEM (n = 4 per group). \*P \< 0.05; \*\*P \< 0.01; \*\*\*P \< 0.001 (one‐way [anova]{.smallcaps} with Tukey\'s post‐hoc test). 5‐Aza‐dc, 5‐Aza‐2′‐deoxycytidine.](JNE-28-0-g005){#jne12371-fig-0005}

Discussion {#jne12371-sec-0018}
==========

It has been suggested that epigenetic mechanisms underlie brain plasticity [19](#jne12371-bib-0019){ref-type="ref"}, [20](#jne12371-bib-0020){ref-type="ref"}, [39](#jne12371-bib-0039){ref-type="ref"}, a process in which stable modulation of gene expression occurs. In this regard, the SON represents a perfect model because it undergoes huge plastic changes in response to dehydration and salt loading to cope with the increased demand for *Avp* synthesis [14](#jne12371-bib-0014){ref-type="ref"}. Thus, we proposed that the *Avp* gene maybe a target for epigenetic regulation in osmotic stress. The clustering of CpGs upstream of the transcriptional start site of *Avp*, a region that contains transcription factor binding motifs, implied that epigenetic modification of this segment of DNA maybe important for modulation of *Avp* transcription. We show that demethylation of the *Avp* promoter by 5‐Aza treatment of hypothalamic 4B cells greatly increases basal and stimulated *Avp* synthesis, suggesting that methylation acts to inhibit *Avp* synthesis. We also show DNA demethylation and *de novo* methylation of CpG residues in the proximal *Avp* promoter in the dehydrated, but not the salt‐loaded, rat SON.

We used hypothalamic 4B cells to investigate *Avp* promoter methylation *in vitro*. These cells have widely been used to study both corticotrophin‐releasing hormone and *Avp* transcription [38](#jne12371-bib-0038){ref-type="ref"}, [40](#jne12371-bib-0040){ref-type="ref"}, [41](#jne12371-bib-0041){ref-type="ref"}. Hypothalamic 4B cells were found to express *Avp* and treatment with the DNA methyltransferase inhibitor 5‐Aza dramatically increased *Avp* synthesis by forskolin treatment. Demethylation of gene promoter regions has been shown to increase the accessibility of DNA for activation by transcription factors [34](#jne12371-bib-0034){ref-type="ref"}. Notably, expression of house keeping gene *Rpl19* was not affected by treatment with 5‐Aza. Therefore, this cell line represents a useful model for the future investigation of transcriptional regulation of the *Avp* gene by methylation.

Increased neuronal activity has been linked with global methylation changes in the brain. In mouse dentate gyrus neurones, activation was shown to be associated with active demethylation or *de novo* methylation of specific genes related to neuronal plasticity [20](#jne12371-bib-0020){ref-type="ref"}. It well known that *c‐Fos*, a marker of neuronal activity, is dramatically increased in abundance in magnocellular neurones of the SON by hyperosmotic stress [42](#jne12371-bib-0042){ref-type="ref"}, [43](#jne12371-bib-0043){ref-type="ref"}, as indicated in the present study by increased mRNA expression. With this in mind, we investigated mRNA expression of genes regulating DNA methylation processes in the SON. The expression of DNA methyltransferases, *Dnmt1* and *Dnmt3a*, has been described in the adult brain [21](#jne12371-bib-0021){ref-type="ref"}, and we observed the expression of these genes in the SON, although levels were not altered by dehydration or salt loading. Nevertheless, one member of *Tet* family, *Tet2*, known to be involved in active and passive demethylation of DNA [23](#jne12371-bib-0023){ref-type="ref"}, was altered by both stimuli in the SON. Interestingly, the knockdown of *Tet2* expression *in vitro* has been associated with hypermethylation of DNA [44](#jne12371-bib-0044){ref-type="ref"}, [45](#jne12371-bib-0045){ref-type="ref"}. Therefore, we reasoned that decreased *Tet2* may result in hypermethylation of CpG sites in the SON *Avp* promoter.

The only report of methylation status regarding the proximal *Avp* promoter region was in the mouse PVN, where sparse methylation was reported [27](#jne12371-bib-0027){ref-type="ref"}. Indeed, previous studies on methylation of the *Avp* gene have examined regions outside of the proximal promoter, focusing on more distal extremities of the promoter or on an enhancer within the intergenic region linking the *Avp* and oxytocin genes [25](#jne12371-bib-0025){ref-type="ref"}, [26](#jne12371-bib-0026){ref-type="ref"}, [27](#jne12371-bib-0027){ref-type="ref"}. No study has sought to clarify the steady‐state methylation status of the *Avp* gene in magnocellular neurones of the PVN or in the SON. We have addressed this issue in the present study. To our surprise, methylation increased at CpG2, 3, 4, 6 and 7 only in dehydrated animals, highlighting that methylation of these CpGs is unstable. The fact that decreased Tet2 expression was observed in SONs of both dehydrated and salt‐loaded animals suggests that Tet2 may not be responsible for increased *Avp* promoter methylation in dehydration.

Notably, methylation levels were higher at CpG3, which resides in the middle of the CRE, and at CpG2 and CpG4, which flank this motif. Methylation at CRE sites has been shown to inhibit CREB mediated transcription [46](#jne12371-bib-0046){ref-type="ref"}, [47](#jne12371-bib-0047){ref-type="ref"}. Furthermore, promoter deletion studies in cell line JEG3 showed that deletion of both CRE sites significantly reduced forskolin stimulation of the *Avp* promoter [33](#jne12371-bib-0033){ref-type="ref"}. We have previously reported *Creb3l1* as a transcription factor of the *Avp* gene in the rat hypothalamus [30](#jne12371-bib-0030){ref-type="ref"}. A G‐box element (GCCCACGTGTGT) that flanks the previously identified E‐box enhancer element (CACGTG) was identified as a putative binding site for CREB3L1. When we deleted the core nucleotides (ACGT) from this motif, which corresponds to CpG5, *Avp* promoter activity dropped significantly, confirming the importance of this site in *Avp* promoter activity. It is interesting that the methylation status of CpG5 was the only CpG not affected by dehydration in the SON, perhaps suggesting the stringent regulation of this site for appropriate *Avp* transcription. The increased methylation of individual CpGs may alter promoter activity by interfering with the DNA binding sites of proteins that affect *Avp* transcription. Increased promoter methylation is commonly associated with transcriptional silencing, although there is evidence that methylation can also stimulate gene expression [24](#jne12371-bib-0024){ref-type="ref"}, [34](#jne12371-bib-0034){ref-type="ref"}. What we do know is that demethylation of the *Avp* promoter *in vitro* increases *Avp* expression, suggesting that methylation silences the *Avp* gene. In agreement, CpG methylation at sites 3 and 4 inversely correlated with Avp expression in control SON samples, suggesting that DNA methylation acts to confer *Avp* gene silencing *in vivo*. It is important to note that, in dehydration, *Avp* promoter methylation and *Avp* expression both increased in the SON. Therefore, we cannot rule out the possibility of methylation having a positive influence on *Avp* transcription *in vivo*.

In salt‐loaded animals, there were no changes in *Avp* promoter methylation in the SON. One explanation could be the physiological differences between these two osmotic stimuli. We recently compared the physiological and transcriptome responses to dehydration and salt loading in the rat SON [16](#jne12371-bib-0016){ref-type="ref"}. In the present study, we identified several fundamental differences between dehydration and salt loading in terms of natriuresis, drinking behaviour and circulating hormone levels. Despite these differences, we found that the transcriptional response by the SON was very stable, leading to the hypothesis that the SON may not be able to discriminate between these two osmotic cues. Indeed, both dehydration and salt loading result in significant increases in plasma osmolality compared to controls, although we found no difference when comparing dehydration with salt loading [16](#jne12371-bib-0016){ref-type="ref"}.

In the absence of drinking fluid, both extracellular and intracellular fluid volumes decrease, leading to increased plasma osmolality and, unlike salt loading, hypovolaemia [48](#jne12371-bib-0048){ref-type="ref"}, [49](#jne12371-bib-0049){ref-type="ref"}. Acute hypovolaemia, which can be caused by haemorrhaging or, pharmacologically, by polyethylene glycol injection into the rat, increases AVP secretion from the posterior pituitary, and this is accompanied by increased synthesis of *Avp* in the PVN and SON [3](#jne12371-bib-0003){ref-type="ref"}, [5](#jne12371-bib-0005){ref-type="ref"}, [9](#jne12371-bib-0009){ref-type="ref"} in the absence of osmotic stimulation [3](#jne12371-bib-0003){ref-type="ref"}. A decrease in plasma volume of approximately 15--20% has been shown to increase *Avp* synthesis by approximately two‐fold in the SON and PVN in acute experiments. This raises the question of why the two stimuli (i.e. dehydration and salt loading) similarly increase *Avp* mRNA levels by approximately two‐fold. Indeed, a greater increase in *Avp* synthesis would be predicted in dehydrated compared to salt‐loaded animals in response to both increased plasma osmolality, as well as hypovolaemia provoked by this stimulus. Therefore, the formation of new epigenetic marks on the *Avp* promoter in dehydration may act to control synthesis of *Avp*, which is being driven by a combination of increased plasma osmolality and hypovolaemia. In support of this concept, a study of sustained hypovolaemia produced by injection of the diuretic furosemide showed that plasma AVP was increased by 8 h but decreased by 32 h, despite further decreases in blood volume [10](#jne12371-bib-0010){ref-type="ref"}. It was proposed that this decrease in plasma AVP may be a result of an adaptive resetting of volume control mechanisms. Unfortunately, *Avp* mRNA expression was not reported. However, Hayashi *et al*. [9](#jne12371-bib-0009){ref-type="ref"} showed that acute hypovolaemia can still induce *Avp* synthesis in the PVN and SON of rats dehydrated for 3 days. This ability to increase *Avp* expression may underlie the differing mechanisms governing chronic versus acute hypovolaemia [10](#jne12371-bib-0010){ref-type="ref"}.

The differences in plasma AVP, oxytocin and angiotensin II levels between dehydration and salt loading [16](#jne12371-bib-0016){ref-type="ref"} may also influence DNA methylation. It has been suggested that the methylation status of the *Avp* gene is maintained by the hormonal environment [25](#jne12371-bib-0025){ref-type="ref"}. Castration of rats was shown to increase methylation of two CpGs in the bed nucleus of the stria terminalis *Avp* promoter. This methylation was successfully reversed by the administration of testosterone. We have previously described differences in circulating angiotensin II in dehydrated and salt‐loaded animals [16](#jne12371-bib-0016){ref-type="ref"} and there is evidence that angiotensin II influences methylation [50](#jne12371-bib-0050){ref-type="ref"}, although any effects on methylation patterns in the brain are not known. The circumventricular organs, such as the subfornical organ (SFO) and organum vasculosum lamina terminalis (OVLT), lack a functional blood--brain barrier and thus are sensitive to changes in circulating hormones [49](#jne12371-bib-0049){ref-type="ref"}. The SFO and OVLT expresses angiotensin II type 1 receptor [51](#jne12371-bib-0051){ref-type="ref"} and the expression of this receptor is increased in the SFO by dehydration [52](#jne12371-bib-0052){ref-type="ref"}. The SFO directly projects to AVP expressing magnocellular neurones in the SON and electrophysical studies have shown that stimulation of the SFO affects AVP neurones [53](#jne12371-bib-0053){ref-type="ref"}. Therefore, it is possible that the increased circulating levels of angiotensin II in dehydration, via activation of angiotensin II type 1 receptor in the SFO, may influence *Avp* methylation events in the SON.

One of the limitations of investigating DNA methylation patterns in complex tissues such as the brain is the number of different cellular phenotypes in punch samples. In the SON, there are primarily two neuronal phenotypes (either *Avp* or oxytocin), although this nucleus also contains glial and vascular cellular phenotypes. Consequently, DNA will be extracted from all these cell types and thus contributes to the *Avp* promoter methylation profiles in the present study. Although it is not possible to state in which cell types these promoter changes occur, we observed a strong correlation at specific methylation landmarks with heteronuclear *Avp* expression in control animals, which implied that the methylation profiles may be important in maintaining steady‐state *Avp* expression in the SON. We also showed, by mutation of individual CpG sites, that these residues are important for regulating *Avp* promoter activity in cell lines.

Children and adolescents fail to completely replete their hydrational needs by drinking water or other fluids. This has led some to speculate that, over the long‐term, such deficiencies may result in a low level of dehydration and perhaps even hypovolaemia, with potential consequences later in life [54](#jne12371-bib-0054){ref-type="ref"}. Indeed, in the elderly, disturbances in serum sodium and blood volume are major causes of hospital admissions [55](#jne12371-bib-0055){ref-type="ref"}. Our data suggest that epigenetic regulation of the proximal *Avp* promoter may be an important mechanism in controlling the *Avp* synthesis in response to dehydration. We speculate that this extra level of regulation may be necessary to co‐ordinate the dual inputs received in this nucleus derived from increased plasma osmolality and hypovolaemia provoked by decreased blood volume in chronic dehydration. The stability or indeed the longevity of these newly established epigenetic marks has yet to be determined. The striking differences in methylation patterns that exist in the *Avp* promoter of dehydrated and salt‐loaded rat are likely to be important for furthering our understanding of *Avp* transcriptional control.
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